Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Estee Lauder, N.J. Law Firm Tangle In Second Suit Over Anti-Aging Claims

This article was originally published in The Rose Sheet

You may also be interested in...



Top Stories Of 2013: Retailers, Firms Self-Regulate As Consumer Power Grows

“The Rose Sheet” offers an overview of the year in cosmetics, analyzing 2013’s biggest news and the publication’s most-read stories. Highlights include industry efforts in the U.S. to negotiate a legislative proposal with FDA, movement among retailers to implement cosmetic safety standards and an uptick in class-action litigation targeting alleged misleading personal-care claims.

Plaintiffs Suffer Setback In Suit Disputing “Magnetic” Dial For Men Claims

Plaintiffs strike out with women and a California district court judge as multiple claims are dismissed in a suit alleging false advertising for Dial for Men Magnetic body wash, which evidently does not guarantee attention from the opposite sex.

Aggressive Claims, FDA Warnings Make Beauty A Bull’s Eye For Litigation

Class-action suits against beauty firms on the rise as industry pushes the envelope with claims and FDA warning letters draw attention from class-action law firms, legal experts note. Hogan Lovells attorney Mark Goodman says: “I don’t see this [trend] going away anytime soon.”

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018721

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel